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The hypoxia-response pathway modulates RAS/
MAPK–mediated cell fate decisions in Caenorhabditis
elegans
Sabrina Maxeiner1,2, Judith Grolleman3, Tobias Schmid1, Jan Kammenga3 , Alex Hajnal1
Animals need to adjust many cellular functions to oxygen
availability to adapt to changing environmental conditions. We
have used the nematode Caenorhabditis elegans as a model to
investigate how variations in oxygen concentrations affect cell
fate speciﬁcation during development. Here, we show that sev-
eral processes controlled by the conserved RTK/RAS/MAPK
pathway are sensitive to changes in the atmospheric oxygen
concentration. In the vulval precursor cells (VPCs), the hypoxia-
inducible factor HIF-1 activates the expression of the nuclear
hormone receptor NHR-57 to counteract RAS/MAPK–induced
differentiation. Furthermore, cross-talk between the NOTCH and
hypoxia-response pathways modulates the capability of the VPCs
to respond to RAS/MAPK signaling. Lateral NOTCH signaling
positively regulates the prolyl hydroxylase EGL-9, which pro-
motes HIF-1 degradation in uncommitted VPCs and permits RAS/
MAPK–induced differentiation. By inducing DELTA family NOTCH
ligands, RAS/MAPK signaling creates a positive feedback loop
that represses HIF-1 and NHR-57 expression in the proximal VPCs
and keeps them capable of differentiating. This regulatory net-
work formed by the NOTCH, hypoxia, and RAS/MAPK pathways
may allow the animals to adapt developmental processes to
variations in oxygen concentration.
DOI 10.26508/lsa.201800255 | Received 26 November 2018 | Revised 16 May
2019 | Accepted 17 May 2019 | Published online 24 May 2019
Introduction
The RAS/MAPK pathway regulates cell growth, differentiation,
proliferation, apoptosis, and migration in all metazoans (Simanshu
et al, 2017). Constitutively activating mutations in HRAS, NRAS, or
KRAS are among the most frequent tumor-initiating mutations in
human cancer. In Caenorhabditis elegans, RAS/MAPK signaling is
involved in several developmental processes, such as the speci-
ﬁcation of the excretory duct cell precursor, the differentiation and
maturation of meiotic germ cells or the development of the her-
maphrodite vulva (Sternberg, 2005; Sundaram, 2006). During vulval
development, an EGF-like ligand (LIN-3) secreted by the gonadal
anchor cell (AC) activates EGFR/RAS/MAPK signaling in the adjacent
vulval precursor cells (VPCs) through the EGF receptor (LET-23)
pathway (Fig 1A). Strong activation of the RAS/MAPK signaling
pathway in P6.p, the VPC located closest to the AC, induces the
primary (1°) cell fate and up-regulates the expression of DELTA-like
DSL ligands, which activate lateral NOTCH signaling in the adjacent
VPCs (Chen & Greenwald, 2004). NOTCH performs two distinct
functions during vulval induction (VI). First, before and after the ﬁrst
VPC division, NOTCH signaling maintains the VPCs competent, that
is, capable of responding to the inductive AC signal (Wang &
Sternberg, 1999). Second, strong NOTCH activation in P5.p and
P7.p, which are the neighbors of P6.p, inhibits MAPK signaling and
directly speciﬁes the secondary (2°) fate (Berset et al, 2001; Yoo
et al, 2004). The distal VPCs (P3-4.p and P8.p) that receive neither
the EGFR/RAS/MAPK nor NOTCH signal adopt the tertiary (3°),
uninduced fate. As a result, an invariant 3°-3°-2°-1°-2°-3° cell fate
pattern is established. Activating (gain-of-function) mutations in
the RAS/MAPK pathway lead to the ectopic induction of distal VPCs
and a multivulva (Muv) phenotype, whereas loss-of-function mu-
tations in RAS/MAPK pathway components cause a vulvaless (Vul)
phenotype. Thus, the average number of induced VPCs per animal,
termed the VI index, can be used to quantify RAS/MAPK signaling
strength (e.g., VI = 3 in the wild-type, VI < 3 in Vul, and VI > 3 in Muv
mutants) (Schmid et al, 2015).
C. elegans has evolved cellular and behavioral responses to
adapt to variations in oxygen concentration (Semenza, 2001; Gray
et al, 2004). At the cellular level, the hypoxia-response pathway
mediates the adaptation to low oxygen conditions and a switch
from aerobic to anaerobic metabolism. In ambient oxygen, the
C. elegans hypoxia-inducible factor HIF-1 α is hydroxylated by
the prolyl hydroxylase EGL-9 at a speciﬁc proline residue within the
degradation domain (Fig 2A) (Epstein et al, 2001). Hydroxylated HIF-1
interacts with the von Hippel-Lindau E3 ubiquitin ligase VHL-1
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complex and is degraded by the 26S proteasome (Bishop et al,
2004). Under low oxygen concentrations, HIF-1 is stabilized because
of decreased EGL-9 activity and forms a complex with the consti-
tutively expressed HIF-β subunit AHA-1 to promote the expression
of speciﬁc target genes (Bishop et al, 2004; Shen et al, 2005).
We have previously used quantitative genetics to identify
modiﬁers of the RAS/MAPK pathway by comparing two highly
polymorphic C. elegans strains, N2 Bristol and CB4856 Hawaii, which
had been sensitized by introgression of the G13E let-60(n1046) ras
gain-of-function allele (Schmid et al, 2015). Notably, CB4856 Hawaii
exhibits an overall elevated sensitivity to RAS/MAPK signaling
compared with the N2 Bristol reference strain (Milloz et al, 2008;
Schmid et al, 2015). Among the RAS/MAPK modiﬁers identiﬁed were
F44F1.1, which encodes a calpain paralog (F44F1.3), and pfd-3, a
prefoldin orthologous to the human VHL-binding protein 1. Both
genes have independently been identiﬁed in a screen for suppressors
Figure 1. Hypoxia represses RAS/MAPK–mediated differentiation in different tissues.
(A)Overview of vulval development showing the known interactions between the RAS/MAPK and DELTA/NOTCH pathways. During the L2 stage, LIN-3 EGF activates the RAS/
MAPK cascade in P5.p-P7.p. P6.p, in which RAS/MAPK activity is highest, adopts the 1° cell fate, and expresses DSL NOTCH ligands to activate LIN-12 NOTCH signaling
in the adjacent Pn.p cells, which adopt the 2° fate. The uninduced P(3-4).p and P8.p cells adopt the 3° fate and fuse with the surrounding hypodermis. (B) Vulval
phenotypes of the let-60 ras G13Emutation in the N2 Bristol (left) and CB4856 Hawaii (right) backgroundwith varying oxygen concentrations. Solid lines indicate induced 1°
and 2° and arrowheads uninduced 3° VPCs in L4 larvae. (C) VI of N2 Bristol and CB4856 Hawaii let-60 ras G13E mutants raised in varying oxygen concentrations. (D) Effect of
hypoxia on different RTK/RAS/MAPK pathway, bar-1(ga80), lin-12(n137), and lin-12(n137n720) mutants. ΔVI indicates the change in VI of animals raised in 0.5%
compared with controls grown in 21% oxygen. Δ%Muv and Δ%Vul indicate the change in the percentage of animals with VI > 3 and VI < 3, respectively. The absolute VIs at
0.5% oxygen are shown in the rightmost red column. (E) Suppression of the stacked oocyte phenotype in let-60(ga89gf) animals raised at the restrictive temperature by
hypoxia. Arrowheads point at the stacked oocytes formed in the proximal gonad under normoxia. (F) Suppression of the duct cell duplication phenotype in let-
60(n1046gf)mutants by hypoxia. Arrows point at the duct cell nuclei expressing LIN-48::GFP formed under normoxia (top) and hypoxia (bottom). (C, D) Error bars in (C) and
(D) indicate the 95% conﬁdence intervals, and P-values, indicated with ***P < 0.001 and **P < 0.01, were derived by bootstrapping 1,000 samples. (E, F) In (E) and (F), error
bars indicate the standard error of the mean, and P-values were calculated with a Fisher’s exact test. The numbers of animals scored are indicated in brackets. The scale
bars represent 5 μm.
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of the egl-9 prolyl hydroxylase egg-laying–defective phenotype,
suggesting that F44F1.3 and pfd-3 interact with the core hypoxia-
response pathway (Gort et al, 2007). Together, these ﬁndings
suggested that genetic variation in genes controlling the hypoxia-
response pathway might account for the differences in RAS/MAPK
signaling strength between the N2 Bristol and CB4856 Hawaii C.
elegans isolates.
Here, we show that hypoxia inhibits the cellular responses to
RAS/MAPK signaling in different tissues of C. elegans. Surprisingly,
only part of the hypoxic inhibition of RAS/MAPK signaling depends
on HIF-1 activity. We further identify the nuclear hormone receptor
gene nhr-57 as a critical HIF-1 target that opposes RAS/MAPK–
induced differentiation under normoxia and under hypoxia. Finally,
we show that the prolyl hydroxylase EGL-9 is a NOTCH target gene.
By inducing egl-9 expression, lateral NOTCH signaling between the
proximal VPCs promotes HIF-1 degradation and thereby represses
nhr-57 expression at the onset of vulval fate speciﬁcation to keep
the proximal VPCs competent to respond to the inductive AC signal.
This regulatory network allows the adaptation of development to
variations in oxygen availability.
Results
Hypoxia suppresses LET-60 RAS gain-of-function phenotypes in
different tissues
The two polymorphic genes F44F1.1 and pfd-3 have previously been
found to modify RAS/MAPK signaling during vulval development
and to suppress the egg-laying–defective phenotype of egl-9(lf)
mutants (Gort et al, 2007; Schmid et al, 2015). We, thus, asked if
hypoxia modulates RAS/MAPK–mediated cell fate decisions and
whether the differences in RAS/MAPK signaling strength observed
between different C. elegans wild isolates (Milloz et al, 2008)
originate from genetic variation in components of the hypoxia-
response pathway. To this aim, we introduced by CRISPR/Cas9
genome editing the G13E gain-of-function mutation into the N2
Bristol (zh121gf) and CB4856 Hawaii (zh122gf) let-60 ras locus (Beitel
et al, 1990; Arribere et al, 2014). We then determined the VI of N2 let-
60(zh121gf) and CB4856 let-60(zh122gf) animals raised under dif-
ferent oxygen concentrations. Under normoxia (21% O2), CB4856
animals carrying the G13E mutation exhibited a higher VI than N2
animals carrying the same mutation, as had been observed earlier
by introgressing the canonical G13E allele let-60(n1046gf) into the
CB4856 background (Fig 1B and C) (Milloz et al, 2008; Schmid et al,
2015). VI was not signiﬁcantly changed in either strain when the
animals were raised undermild hypoxic conditions of 11%, 7%, or 3%
O2 (Fig 1B and C). However, at 1% O2, the VI decreased in the CB4856
background, and at 0.5% O2, the VI was reduced to the same level in
both strains. Because 0.5% is the lowest O2 concentration, under
which the animals develop to adulthood, we could not test lower O2
concentrations. It, thus, appears that the same baseline level of VI is
reached under severe hypoxia (0.5% O2) irrespective of the genetic
background.
To further investigate the effect of oxygen on RAS/MAPK sig-
naling and rule out allele-speciﬁc effects, we examined the effect of
Figure 2. The hypoxia-response pathway negatively regulates VI under
normoxia.
(A) Schematic overview of the conserved hypoxia-response pathway. The C.
elegans gene names are indicated. (B) Vulval phenotypes of double and triple
mutants between let-60(n1046gf) and components of the hypoxia-response
pathway under normoxia. Solid lines indicate induced 1° and 2° and arrowheads
uninduced 3° VPCs in the L4 larvae. (C) Mutations in the hypoxia-response
pathway change the VI of let-60(n1046gf)mutants. ΔVI indicates the change in VI of
the genotypes relative to let-60(n1046gf) single mutant siblings obtained from the
crosses. Δ%Muv indicates the change in the percentage of animals with VI > 3. The
absolute VIs of the double/triple mutants are shown in the rightmost blue
column. (D) Overexpression of wild-type egl-9::gfp increases the VI. ΔVI indicates
the change in VI of animals carrying a wild-type (dark bars) or hydroxylase
deﬁcient (light bars) multi-copy egl-9::gfp array compared with siblings without
array. Error bars indicate the 95% conﬁdence intervals. P-values, indicated with
***P < 0.001 and **P < 0.01, were derived by bootstrapping 1,000 samples. (E–I, J)
MPK-1 biosensor (ERK-nKTR) activity values measured in the VPCs of mid-L2 larvae
with the indicated mutant backgrounds and (J) comparison of the MPK-1 activity
levels in P6.p across the different genotypes. Relative MPK-1 activity values were
measured as described under the Materials and Methods section. The numbers of
animals scored are indicated in brackets. The scale bar represents 5 μm.
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strong hypoxia (0.5% O2) on different RAS/MAPK pathway
mutants in the N2 Bristol background. We included the Wnt
pathway–mutant bar-1(ga80) and the NOTCH alleles lin-12(n137gf)
and lin-12(n137n720lf) in this analysis. Even though hypoxia had no
effect on the VI in the N2 Bristol wild-type strain (VI = 3, n > 50),
hypoxia reduced the VI in animals carrying rf mutations in let-23
egfr, let-60 ras, or lin-45 raf or in animals expressing an activated
MAPK (MPK-1) from a transgene (mpk-1(gaIs37gf)) (Fig 1D). (Note
that for each genotype, ΔVI indicates the difference in the induction
index between siblings grown at 0.5% and 21% O2.) By contrast, the
increased VI in lin-1(lf) mutants, which encodes an Ets family
transcription factor that represses VI downstream of MPK-1 (Beitel
et al, 1995), was not affected by hypoxia. Moreover, the VI of bar-1
β-catenin or lin-12 notch mutants was not changed by hypoxia,
indicating that hypoxia speciﬁcally affects the activity of or re-
sponse to RAS/MAPK signaling (Fig 1D).
We next examined the effect of hypoxia on other tissues, in which
RAS/MAPK signaling controls different cell fate decisions. The
temperature-sensitive let-60(ga89gf) allele causes an accelerated
exit of meiotic germ cells from the pachytene stage at the restrictive
temperature and results in the stacking of smaller oocytes in the
proximal gonad arms (Fig 1E) (Eisenmann & Kim, 1997). Furthermore,
the excretory system of let-60(n1046gf) mutants frequently con-
tains two duct cells expressing the lin-48::gfpmarker (Fig 1F) (Berset
et al, 2005). Hypoxia partially suppressed the let-60(gf) phenotypes
in both tissues (Fig 1E and F).
The canonical hypoxia-response pathway opposes RAS/
MAPK–induced VI
Because oxygen serves as an essential energy substrate, a re-
duction in the atmospheric oxygen concentration induces the
adaptation of many metabolic processes (Semenza, 2001). In
addition to these immediate metabolic changes, cells activate the
hypoxia-response pathway via the hypoxia-inducible factor HIF-1
to change gene expression. Interestingly, VI was signiﬁcantly
reduced only below a threshold oxygen concentration between 1
and 0.5% oxygen rather than decreasing progressively along an O2
gradient (Fig 1C), suggesting the existence of a regulatory switch
rather than a systemic metabolic effect of hypoxia on RAS/MAPK
signaling. We, thus, examined the genetic interactions between
mutations in the RAS/MAPK and hypoxia-response pathways
under normoxic conditions (21% O2). For this purpose, we cal-
culated the change in VI (ΔVI) between the indicated double
mutants and let-60(n1046gf) single mutant control siblings ob-
tained from each cross (Fig 2B and C). The VI of let-60(n1046gf)
mutants was reduced when combined with the egl-9(sa307lf)
(Darby et al, 1999) or vhl-1(ok161lf) (Epstein et al, 2001) alleles,
whereas the VI was increased in combination with the hif-1(ia04)
allele (Jiang et al, 2001). Because the ia04 deletion in hif-1 does not
affect all isoforms, we created a larger hif-1 deletion (zh111) that
likely represents a null allele (Fig S1A). let-60(n1046gf); hif-
1(zh111lf) double mutants exhibited an even stronger increase in
VI (Figs 2C and S1B). Moreover, let-60(n1046gf); egl-9(sa307lf) hif-
1(ia04lf) triple mutants exhibited the same increase in VI as let-
60(n1046gf); hif-1(ia04lf) double mutants, indicating that hif-1
counteracts RAS/MAPK signaling downstream of egl-9 prolyl
hydroxylase (Fig 2A–C). egl-9(sa307lf) also reduced the VI of
mutants in other RAS/MAPK pathway components, such as the
guanine nucleotide exchange factor sos-1 or the raf homolog lin-
45 (Fig S2) (Sternberg, 2005).
Because HIF-1 is efﬁciently degraded under normoxia, the in-
creased VI caused by hif-1(lf) mutations under normoxia was
somewhat surprising. It, thus, appears that low residual levels of
HIF-1 present under normoxia are sufﬁcient to oppose RAS/MAPK
signaling. We, therefore, investigated the effect of wild-type and
hydroxylase deﬁcient egl-9::gfp transgenes on VI (Shao et al, 2009).
A wild-type egl-9::gfp transgene efﬁciently rescued the reduced VI
of let-60(n1046gf); egl-9(sa307lf) and further increased the VI of let-
60(n1046gf) single mutants (Fig 2D). By contrast, the hydroxylase-
deﬁcient egl-9::gfp transgene had no effect on the VI in either
background. We conclude that EGL-9 enhances RAS/MAPK–
induced VPC differentiation by inhibiting HIF-1 protein stability,
rather than by acting through a prolyl hydroxylase-independent
pathway (Shao et al, 2009; Park et al, 2012). Moreover, EGL-9 en-
zymatic activity appears to be a rate-limiting step in the inhibition
of VI by HIF-1, as the introduction of additional transgenic copies of
egl-9 into an egl-9(wt) background caused a further increase in the
VI. Thus, low levels of HIF-1 that persist under normoxia are suf-
ﬁcient to repress VI.
The hypoxia pathway modiﬁes the response to rather than the
activity of the RAS/MAPK pathway
Even though mutations in the hypoxia pathway mutants signiﬁ-
cantly affected VI in sensitized genetic backgrounds, egl-
9(sa307lf),hif-1(ia04lf), or hif-1(zh111lf) single mutants raised at
normoxia or hypoxia exhibited normal vulval development (VI = 3,
n > 50 for each condition and genotype). Because VI is very robust
even under varying environmental conditions (Fe´lix & Barkoulas,
2012), small alterations in RAS/MAPK pathway activity caused by
hypoxia or mutations in the hypoxia-response pathway may not
manifest as a vulval fate change, unless the RAS/MAPK pathway is
simultaneously compromised. Alternatively, the hypoxia pathway
may not directly modify RAS/MAPK pathway activity but rather
inhibit the response of the VPCs to RAS/MAPK signaling. To dis-
tinguish between these two scenarios, we directly measured MPK-1
activity in the VPCs of hypoxia pathway mutants at the mid-L2 stage
that were grown under normoxia. For this purpose, we used a
recently developed ERK-nKTR activity biosensor (de la Cova et al,
2017) (for a detailed description of the biosensor quantiﬁcation, see
the Materials and Methods section). All mutant backgrounds
exhibited the highest MPK-1 activity levels in P6.p, as observed in
wild-type controls (Fig 2E–I). Furthermore, we found no signiﬁcant
decrease in MPK-1 activity in P6.p of egl-9(sa307) and no increase in
hif-1(ia04lf) or hif-1(zh111lf) animals relative to the wild-type con-
trols (Fig 2J). (All P-values in a one-way ANOVA test with Dunnett’s
multiple comparison correction were above 0.05.) Thus, we did not
detect substantial changes in MPK-1 activity within the dynamic
range of the ERK-nKTR biosensor. We conclude that the hypoxia-
response pathway attenuates the response of the VPCs to MAPK
signaling, rather than directly inhibiting RAS/MAPK pathway
activity.
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HIF-1 inhibits VI cell autonomously in the VPCs
Because HIF-1 exerts both cell autonomous and cell non-
autonomous functions (Shao et al, 2010; Sendoel et al, 2010), we
investigated in which tissue HIF-1 functions to inhibit VI. First, we
analyzed the expression pattern of a translational hif-1::gfp re-
porter (Sendoel et al, 2010). The hif-1::gfp reporter was undetectable
under normoxia, but visible in many somatic cells, including the
VPCs and the intestinal cells in egl-9(sa307lf) or vhl-1(ok161) mu-
tants (Fig 3A). Because we had previously described a cell non-
autonomous suppression of VI via the amx-2 monoamine oxidase
acting in intestinal cells (Schmid et al, 2015) and because ex-
pression of egl-9::gfp was prominent in intestinal cells, we tested a
possible function of HIF-1 in the intestine and VPCs. To this aim, we
performed Pn.p cell–speciﬁc and intestine-speciﬁc RNA interfer-
ence using rde-1(ne219lf); let-60(n1046gf) RNAi-resistant mutants
expressing rde-1(wt) from the Pn.p cell–speciﬁc lin-31 and the
intestine-speciﬁc elt-2 promoters (Schmid et al, 2015). Whereas the
knockdown of hif-1 in the intestinal cells did not change the VI, Pn.p
cell–speciﬁc hif-1 RNAi signiﬁcantly increased the VI compared with
empty vector control animals (Fig 3B). It is noteworthy that, for
unknown reasons, the genetic background used to establish the
tissue-speciﬁc RNAi strains also affected the VI of the let-
60(n1046gf) mutation, as reported previously (Schmid et al, 2015).
Nevertheless, these results indicate that HIF-1 acts autonomously
in the VPCs to oppose RAS/MAPK signaling during VI.
EGL-9 is a NOTCH target gene
Whereas hif-1::gfp reporter expression was not detectable in wild-
type animals raised under normoxia (Fig 3A), the expression of the
functional egl-9::gfp reporter could be observed in the VPCs and
their descendants throughout vulval development (Fig 3C and D). At
the onset of VI in mid L2 larvae, the egl-9::gfp reporter was
expressed in all VPCs, although expression levels were slightly
higher in the three proximal VPCs P5-7.p than the three distal VPCs
P3.p, P4.p, and P8.p (Fig 3C, top panel). In late-L2/early-L3 stage
animals, EGL-9::GFP expression remained prominent in the proxi-
mal VPCs but decreased in the distal VPCs as they started dividing
(Fig 3C, second panel). After completion of the ﬁrst round of VPC
divisions in mid-L3 larvae, EGL-9::GFP expression faded in the 1°
P6.p descendants and increased in the 2° P5.p and P7.p de-
scendants (Fig 3C, third panel).
This expression pattern suggested that either RAS/MAPK sig-
naling inhibits or lateral DELTA/NOTCH signaling induces EGL-9::
GFP expression in the VPCs. We distinguished between these two
scenarios by introducing the egl-9::gfp reporter into let-60(n2021rf),
lin-12(n137n720lf), and lin-12 (n137gf) mutants and quantifying the
EGL-9::GFP signal intensities. EGL-9::GFP expression was strongly
reduced in let-60(n2021rf); egl-9(sa307lf)mutants (Fig 3C and E; note
that for unknown reasons we only obtained viable progeny from
let-60(n2021rf)mutants carrying the egl-9::gfp transgene in the egl-
9(sa307lf) background). Furthermore, EGL-9::GFP expression was
absent in the VPCs of lin-12(n137n720lf) mutants, whereas lin-
12(n137gf) mutants showed strong and uniform expression in all
VPCs (Fig 3C, F, and G). Note that, because no AC is formed in lin-
12(n137gf) mutants, the RAS/MAPK is not activated in lin-12(n137gf)
mutants. Furthermore, we identiﬁed eight predicted CSL (LAG-1)-
binding sites (G/ATGGGAA) within a 6-kb egl-9 genomic region (Fig
S3), which is a signiﬁcant enrichment in CSL-binding site frequency
(one site per 8 kb corresponds to a random distribution) and
comparable with the known LIN-12 NOTCH target genes lip-1, lin-12,
lag-1, or glp-1 (Christensen et al, 1996; Berset et al, 2001; Yoo &
Greenwald, 2005). Finally, we tested if egl-9 modulates lateral
NOTCH signaling strength by determining the VI of lin-12; egl-
9(sa307lf) double mutants. The egl-9(sa307lf) allele neither affected
the VI of lin-12(n137n720lf) nor of lin-12(n137gf) mutants (Fig S4).
Taken together, we conclude that EGL-9 does not regulate LIN-12
NOTCH signaling but rather acts downstream of LIN-12 NOTCH to
down-regulate HIF-1. LIN-12 up-regulates EGL-9::GFP expression
independently of RAS/MAPK signaling, and the enrichment of CSL-
binding sites in the egl-9 locus suggests that egl-9 may be a direct
LIN-12 NOTCH target gene. Because RAS/MAPK signaling induces
the expression of the DSL NOTCH ligands (Chen & Greenwald, 2004)
(Fig 1A), inhibiting RAS/MAPK signaling most likely reduces EGL-9::
GFP expression indirectly via the loss of NOTCH activation.
The HIF-1 target gene nhr-57 inhibits VI under normoxia
HIF-1 up-regulates the expression of numerous target genes under
hypoxia and induces multiple cellular responses (Semenza, 2001).
Previous studies have identiﬁed a large number of HIF-1 regulated
genes in C. elegans (Bishop et al, 2004; Shen et al, 2005). We used the
available expression data to screen for genes that act downstream
of HIF-1 and negatively regulate VI. We selected a total of 80
predicted HIF-1 target genes that exhibited an at least twofold
induction by HIF-1 and performed RNAi in let-60(n1046gf); egl-
9(sa307lf) and let-60(n1046gf); hif-1(zh111lf) double mutants grown
under normoxia (Tables S1 and S2). We used these two double-
mutant backgrounds to distinguish between RAS/MAPK pathway
modiﬁers that are partially or fully HIF-1 dependent. We hypoth-
esized that the knockdown of a gene that inhibits VI and depends
on HIF-1 for its expression should increase the VI of let-60(n1046gf);
egl-9(sa307lf) mutants in which HIF-1 is stabilized. However,
knockdown of the same gene in let-60(n1046gf); hif-1(zh111lf)
mutants should not increase the VI because this gene would not be
expressed in the absence of HIF-1.
Based on these criteria, we identiﬁed a single HIF-1 target gene,
nhr-57, as a negative regulator of RAS/MAPK-induced VPC differ-
entiation (Fig 4A and Table S1). nhr-57 encodes a nuclear hormone
receptor similar to the Drosophila estrogen-related receptor ERR2
and the vertebrate glucocorticoid hormone receptor NR3C1 (Shaye
& Greenwald, 2011). We next used the nhr-57(tm4533lf) deletion
allele to conﬁrm that NHR-57 acts as an inhibitor of VPC differ-
entiation. The VI of let-60(n1046gf); hif-1(zh111lf); nhr-57(tm4533lf)
triple mutants was not signiﬁcantly different from let-60(n1046gf);
hif-1(zh111lf); nhr-57(+) control siblings (Fig 4B). However, the nhr-
57(tm4533lf) allele increased the VI of let-60(n1046gf); egl-9(sa307lf)
double and of let-60(n1046gf) single mutants compared with the
corresponding nhr-57(+) control siblings.
We next assessed the expression pattern of NHR-57 by con-
structing a translational nhr-57::gfp reporter transgene. The re-
porter includes the complete nhr-57 promoter/enhancer region
and contains the predicted HIF-1–binding sites (Miyabayashi et al,
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1999; Shen et al, 2006). In animals raised under normoxia, the nhr-
57::gfp reporter was weakly expressed in several somatic cells in-
cluding the intestinal cells, but not in the VPCs before VI. After the
ﬁrst round of VPC divisions in mid-L3 larvae, nhr-57::gfp expression
became visible in the descendants of the uninduced distal VPCs but
remained undetectable in the descendants of the induced proximal
Figure 3. egl-9 is a NOTCH target that promotes HIF-1 degradation in the induced VPCs.
(A) HIF-1::GFP expression in wild-type, egl-9(sa307lf), and vhl-1(ok161lf) larvae before VI. Arrowheads point at the nuclei of the VPCs. (B) Pn.p cell– and gut-speciﬁc hif-1
RNAi (see main text and the Material and Methods section). ΔVI indicates the change in VI in hif-1 RNAi compared with empty vector–treated control animals. Error
bars indicate the 95% conﬁdence interval, and P-values were derived by bootstrapping 1,000 samples. (C) EGL-9::GFP expression in a wild-type mid-L2 larva (top
panel) at the onset of VI, a late-L2/early-L3 larva before the proximal and after the distal VPCs had divided (second panel) and a mid-L3 larva after all VPCs had divided
once (third panel, Pn.px stage). The arrowheads point at the VPC nuclei and the small arrows at the nuclei of ventral nerve cord neurons expressing EGL-9::GFP.
Expression in let-60 ras(n2021rf), lin-12 notch(n137n720lf), and lin-12 notch(n137gf) mutants is shown in mid-L3 larvae, after the ﬁrst round of VPC divisions had been
completed (Pn.px stage). Induced VPCs are underlined. The scale bar represents 5 μm. (D) Schematic representation of the wild-type EGL-9::GFP pattern during
vulval development. (E–G) Quantiﬁcation of EGL-9::GFP expression in the four genotypes shown in (C) after VI (early to mid L3 and at the Pn.pxx stage in (G)). Error bars
indicate the standard error of the mean, and P-values, indicated with ***P < 0.001 and *P < 0.05, were calculated in a two-tailed t test. The numbers of animals scored are
indicated in brackets.
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VPCs until they had completed their last round of division and
terminally differentiated (Fig 4D and E). Consistent with its function
as an HIF-1 target, NHR-57::GFP expression was up-regulated in the
VPCs of egl-9(sa307lf) mutants with the signal being most prom-
inent in the descendants of uninduced VPCs (Fig 4D and E). Taken
together, we propose that LIN-12 NOTCH signaling induces EGL-9
expression in the proximal VPCs to counteract the inhibitory effect
of HIF-1 and its target NHR-57 on VPC fate speciﬁcation.
NHR-57 mediates the HIF-1–dependent and HIF-1–independent
hypoxic inhibition of VI
Our results so far have suggested that under normoxic conditions,
EGL-9 induces HIF-1 degradation to prevent the HIF-1 target NHR-57
from inhibiting vulval differentiation (Fig 4A and B). However,
HIF-1–independent factors also play a role in the transcriptional
response to hypoxia (Shen et al, 2005; Padmanabha et al, 2015). We,
thus, investigated if the inhibitory effect of hypoxia on vulval de-
velopment depends entirely on HIF-1 activity. Surprisingly, the VI of
let-60(n1046gf); hif-1(lf) double and let-60(n1046gf); egl-9(sa307lf)
hif-1(ia04lf) triple mutants was signiﬁcantly decreased under
hypoxia (Fig 4C). Therefore, the reduction in VI under hypoxia only
partially depends on HIF-1.
NHR-57 appeared to be a good candidate for a factor that
mediates the HIF-1–independent effect of hypoxia for a number of
reasons. First, the translational nhr-57::gfp reporter was expressed
under normoxia in cells that also expressed the egl-9::gfp reporter.
Second, nhr-57::gfp expression in the VPCs of egl-9(sa307lf)mutants
that uniformly express hif-1::gfp (Fig 3A) was not uniform (Fig 4D),
pointing at a regulation of nhr-57 expression by additional factors
Figure 4. The HIF-1 target NHR-57 inhibits RAS/MAPK signaling under normoxia and hypoxia.
(A) Knock-down of nhr-57 increases the VI of let-60(n1046gf) in an egl-9(sa307lf) but not in a hif-1(zh111lf) background. ΔVI and Δ%Muv indicate the changes in VI
and percentage of animals with VI > 3 after nhr-57 RNAi compared with empty vector–treated control animals. (B) Deletion of the nhr-57(tm4533lf) allele increases the VI of
let-60(n1046gf) single and let-60(n1046gf); egl-9(sa307lf) double mutants but has no effect in a let-60(n1046gf); hif-1(zh111lf) background. ΔVI and Δ%Muv indicate
the changes in VI and the percentage of animals with VI > 3 compared with nhr-57(+) control siblings. (C) Hypoxic treatment decreases the VI in the hif-1(ia04lf),
hif-1(zh111lf), and egl-9(sa307lf) hif-1(ia04lf) but not the nhr-57(tm4533lf) background. ΔVI and Δ%Muv indicate the changes in VI and percentage of animals with VI > 3
raised in hypoxia compared with normoxia. Error bars indicate 95% conﬁdence intervals, and P-values, indicated with ***P < 0.001 and **P < 0.01, were derived by
bootstrapping 1,000 samples. The numbers of animals scored are indicated in brackets. (D) NHR-57::GFP expression pattern in the wild-type (left panels) and egl-9(sa307lf)
(right panels) background in late-L2/early-L3 larvae at the Pn.p stage (top panels), in mid L3 larvae (Pn.px stage) after induction (middle panels), and at the end of
vulval differentiation (bottom panels). Arrowheads and solid lines point at the nuclei of the induced or uninduced VPCs and their descendants, respectively. The
scale bar represents 5 μm. (E) Schematic representation of the NHR-57::GFP pattern during vulval development in the wild-type (left) and in an egl-9(sa307lf) background
(right).
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besides HIF-1. Third, the transcription of nhr-57 was signiﬁcantly
enhanced under hypoxia even in the absence of HIF-1 activity
(Bishop et al, 2004). Together, these ﬁndings suggested that NHR-57
integrates multiple inputs together with the HIF-1–mediated hyp-
oxic response. In contrast to let-60(n1046gf); hif-1(lf)mutants, the VI
of let-60(n1046gf); nhr-57(tm4533lf) double mutants did not change
under hypoxia (Fig 4C). Thus, NHR-57 is necessary for both the HIF-
1–dependent and HIF-1–independent repression of VI by hypoxia.
Discussion
We have found that different tissues in C. elegans can modulate
their cellular responses to RAS/MAPK signaling according to the
availability of oxygen. Under limiting oxygen concentrations, en-
ergetically demanding processes that are dispensable for viability,
such as oogenesis or VI, may be suppressed to preserve essential
cellular functions. By connecting the cellular hypoxia response to
an essential developmental signaling pathway, the animals can
adapt their development to ﬂuctuations in oxygen concentration. In
wild-type animals raised under the optimal laboratory growth
conditions, the effect of hypoxia does not manifest as a change in
cell fate speciﬁcation in the tissues we examined. The effect of
hypoxia only becomes apparent if the RAS/MAPK pathway has been
sensitized. However, the hypoxic effect may become relevant when
animals in the wild encounter stressful conditions, in which de-
velopmental robustness is challenged. The capability to adapt to
varying oxygen concentrations could increase developmental
robustness.
The CB4856 Hawaii wild isolate exhibits overall higher levels of VI
than the N2 Bristol reference laboratory strain when grown under
normoxia (Milloz et al, 2008; Schmid et al, 2015) as well as under
mild hypoxic conditions (>3% O2) (this study). Strong hypoxia (<1%
O2) not only reduces vulval differentiation to a baseline level but
also eliminates the difference between the two strains. Thus, dif-
ferences in their hypoxia response may account for some of the
differences in VI between the Bristol N2 and Hawaii CB4856 strains.
Most wild C. elegans isolates, including CB4856, are adapted to
lower oxygen levels and aggregate when grown under normoxia
(Hodgkin & Doniach, 1997; Rogers et al, 2006). Aggregation is often
followed by burrowing, which may further decrease the oxygen
concentrations the animals experience. By contrast, the laboratory
strain N2 Bristol does not aggregate because it has become ha-
bituated to atmospheric oxygen concentrations during the pro-
longed laboratory cultivation (de Bono & Bargmann, 1998). Thus, in
wild strains, the cellular sensitivity to RAS/MAPK signaling may be
elevated to allow development under lower oxygen levels.
We next focused on the process of vulval fate speciﬁcation to
dissect how the hypoxia-response and RAS/MAPK signaling
pathways interact at the molecular level. Because the activity of the
prolyl hydroxylase EGL-9 is a rate-limiting step in the HIF-1 deg-
radation pathway (Fig 2D), the hypoxia-response pathway exerts its
inhibitory effect even under normoxia. This observation allowed us
to investigate the cross-talk between the hypoxia and RAS/MAPK
pathways under standard growth conditions. By screening a se-
lection of candidate genes regulated by HIF-1, we have identiﬁed
the nuclear hormone receptor NHR-57 as a key downstream in-
tegrator of both the HIF-1–dependent and HIF-1–independent
pathways (Fig 5). Because we did not detect signiﬁcant changes in
MAPK biosensor activity in hif-1(lf) or egl-9(lf)mutants, the hypoxia-
response pathway and NHR-57 must act downstream of or in
parallel with the RAS/MAPK pathway. NHR-57 may interact with the
ETS family transcription factor LIN-1, which is an MAPK substrate
that represses VPC differentiation when the RAS/MAPK pathway is
inactive (Beitel et al, 1995; Jacobs et al, 1998; Tan et al, 1998).
Consistent with this hypothesis, multiple genetic and physical in-
teractions between ETS family transcription factors and steroid
hormone receptors have been reported in other systems (Mullick et
al, 2001; Geng & Vedeckis, 2005; Kalet et al, 2013; Cao et al, 2015).
Among the steroid hormone receptors, the glucocorticoid receptor
NR3C1 exhibits closest homology to NHR-57 (Shaye & Greenwald,
2011). Also, NR3C1 accumulates under hypoxia to promote eryth-
ropoiesis (Bauer et al, 1999; Mense, 2006). Although NHR-57 is a
critical HIF-1 target that counteracts RAS/MAPK signaling in the
VPCs, NHR-57 expression appears to be regulated by additional
factors besides HIF-1 (Bishop et al, 2004; Padmanabha et al, 2015).
Similarly, the expression of the mammalian glucocorticoid receptor
NR3C1 is not only regulated by hypoxia but also by serotonin (5-HT)
(Mitchell et al, 1990). It thus seems likely that nhr-57 expression is
controlled by several additional cues besides the HIF-1–induced
up-regulation under hypoxia.
Interestingly, the regulation of egl-9 expression by NOTCH sig-
naling provides a link between the VPC fate speciﬁcation and the
hypoxia-response pathways. This link could be used to modulate
the sensitivity of the VPCs to the inductive signal according to
oxygen concentrations. At the beginning of VI, EGFR/RAS/MAPK
signaling is predominantly activated in the proximal VPCs (P5.p,
P6.p, and P7.p) by the LIN-3 EGF signal secreted from the AC. EGFR/
RAS/MAPK signaling then up-regulates the expression of multiple
DELTA family ligands in P6.p to activate lateral NOTCH signaling in
the neighboring VPCs P5.p and P7.p and focus the inductive signal
on P6.p, the future 1° VPC (Fig 1A) (Berset et al, 2001; Yoo et al, 2004;
Sternberg, 2005). However, in early L3 larvae, both the NOTCH ligand
LAG-2 and its receptor LIN-12 are expressed in all VPCs (Chen &
Greenwald, 2004; Levitan & Greenwald, 1998). Only after VI before
the VPCs divide at the mid-L3 stage, LAG-2 expression becomes
restricted to P6.p, whereas LIN-12 levels decrease in P6.p. Thus,
reciprocal LIN-12 NOTCH signaling between the VPCs during an early
phase of vulval fate speciﬁcation may induce EGL-9 expression to
reduce HIF-1 and NHR-57 levels and keep the proximal VPCs
competent to differentiate (Fig 5A). In line with this model, NOTCH
signaling has previously been shown to maintain the VPCs com-
petent to respond to the inductive LIN-3 EGF signal even after the
VPCs have started dividing (Wang & Sternberg, 1999; Nusser-Stein et
al, 2012). The lack of inductive EGFR/RAS/MAPK and lateral NOTCH
signaling in the distal uninduced VPCs and their descendants re-
sults in higher NHR-57 levels, which reduce their capability to
differentiate. However, under hypoxic conditions, the elevated
NHR-57 levels may render all VPCs less responsive to the inductive
LIN-3 EGF signal (Fig 5B).
The activity of the NOTCH signaling pathway and short-term
hypoxic periods involving activation of the hypoxia-response
pathway are important during normal animal development
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(Patterson& Zhang, 2010; Siebel & Lendahl, 2017). To our knowledge,
prolyl hydroxylases have so far not been implicated in RAS/MAPK or
DELTA/NOTCH–mediated cell fate decisions in other animals.
However, a dependence of mammalian EGLN3 hypoxia-inducible
factor prolyl hydroxylase transcription downstream of NOTCH has
been reported (Ohashi et al, 2011; Li et al, 2012). It remains to be
investigated whether these two signaling pathways are inter-
connected in other organisms in a similar manner as in C. elegans
to couple cell fate decision with oxygen availability.
Materials and Methods
C. elegans alleles
C. elegans strains were maintained at 20°C using standard pro-
cedures (Brenner, 1974) except N2 strains carrying the let-60(ga89)
allele that were maintained at 20°C and shifted to 25°C for mutant
analysis. C. elegans Bristol refers to the wild-type N2 strain and
Hawaii to CB4856 (Erik C Andersen, 2015). The transgenic lines were
generated as described in (Mello et al, 1991). The following mu-
tations and transgenes were used in this study: LGII: let-23(sy1); LG
III: unc-32(e189) lin-12(n137n720), dpy-19(e1259) lin-12(n137),
hT2[bli-4(e937) let-?(q782) qIs48] (I;III). LG IV: let-60(n1046),
let-60(zh121) (this study), let-60(zh122) (this study), let-60(ga89),
let-60(n2021), lin-1(n304), lin-3(e1417), lin-45(sy96). LG V: egl-
9(sa307), hif-1(ia04), hif-1(zh111) (this study), nhr-57(tm4533) (Mitani
lab). LG X: vhl-1(ok161), rde-1(ne219), bar-1(ga80). Transgenes: gaIs37
[lin-31::mpk-1(gf); lin-31::D-mek(gf)] (Lackner & Kim, 1998), iaIs38[egl-
9p::egl-9::tag, unc-119(+)] (Shao et al, 2009), iaEx101[egl-9p::egl-
9(H487A)::tag, unc-119(+)] (Shao et al, 2009), duIs?[elt-2p::rde-1(+);
pRF4], zhEx418[lin-31p::rde-1;myo-2::mCherry], saIs14[lin-48p::gfp],
opIs206[hif-1p::hif-1::gfp::hif-1 39UTR, unc-119(+)] (Sendoel et al,
2010), zhEx605[nhr-57p::nhr-57::gfp:: nhr-57 39UTR, unc-119(+)] (this
study), arTi85[lin-31p::ERK-KTR(NLS3)-mClover-T2A-mCherry-H2B::unc-
54 39UTR, rps-27p::NeoR::unc-54 39UTR] (de la Cova et al, 2017).
Detailed information on the alleles used can be found under
www.wormbase.org.
A list of all strains used can be found in Table S3.
RNAi experiments
RNAi was performed as described in (Kamath et al, 2003). Larvae
were synchronized by hypochloride treatment of gravid adults and
raised on bacteria expressing dsRNA. The empty vector plasmid
L4440 was used as a negative control and dsRNA against rpn-6.1 as a
positive control. VI was scored in the F1 generation. Animals were
Figure 5. EGL-9 inhibits the HIF-1 target NHR-57 from
reducing RAS/MAPK signaling through a DELTA/
NOTCH-induced negative feedback loop.
(A) Model illustrating the cross-talk of the hypoxia-
response, DELTA/NOTCH, and RAS/MAPK pathways at
normoxia. At the onset of VI, before a distinction
between 1° and 2° VPCs is made, lateral DELTA/NOTCH
signaling between the proximal VPCs induces EGL-9
expression to maintain low HIF-1 and NHR-57 levels,
thereby keeping the VPCs competent to respond to
RAS/MAPK signaling. RAS/MAPK signaling, in turn,
promotes the expression of the DELTA family NOTCH
ligands. Distal VPCs lose their competence because of
higher NHR-57 levels and adopt the 3° fate. Thereafter,
NOTCH signaling directly induces the 2° fate and
inhibits RAS/MAPK signaling in P5.p and P7.p. (B) Under
hypoxia, the inhibition of HIF-1 and NHR-57 by EGL-9 is
reduced because of the lack of oxygen and vulval fate
acquisition is compromised. An as-of-yet unidentiﬁed
factor activates NHR-57 during hypoxia independently
of HIF-1.
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anesthetized in in a drop of 5 mM tetramisole and analyzed using
differential interference contrast and ﬂuorescence microscopy.
Staging of the animals used for microscopy analysis
Synchronized population of L1 larvae were obtained by hypo-
chloride treatment of gravid adults and letting the embryos hatch
in S-basal buffer without OP50 bacteria for 16–20 h. Arrested L1
larvae were then fed with OP50 bacteria until they reached the
stage to be analyzed. The developmental stages were further
distinguished using Nomarski image stacks taken along with the
ﬂuorescent images by scoring VPC divisions and the dorsal turning
of the distal tip cell (DTC) and by measuring the gonad length as
described (Kimble & Hirsh, 1979). Developmental stages were
assigned as follows: mid-L2 stage (gonad: 35–75 μm, VPCs undivided,
and DTC not turned), late-L2 stage (gonad: 75–110 μm and DTC not
turned), early-L3 stage (gonad: >110 μmand DTC begins to turn), and
mid-L3 stage (gonad: >110 μm, all VPCs divided once, and DTC
turned).
VI counts
VI was scored by examining worms at the L4 stage under Nomarski
optics as described in (Sternberg & Horvitz, 1986). The number of
VPCs that had adopted a 1° or 2° vulval cell fate was counted for
each animal, and the VI index was calculated by dividing the total
number of induced cells by the number of animals scored. Animals
with a VI > 3 were scored as hyperinduced and animals with VI < 3 as
hypoinduced. The different allele combinations compared were
generated from progeny obtained in the same crosses. The raw data
used to compile the induction graphs shown in the ﬁgures can be
found in Table S4.
ERK-nKTR biosensor quantiﬁcation
MPK-1 activity in the VPCswasmeasured inmid-L2 larvae (Pn.p stage)
using the recently established ERK-nKTR biosensor (arTi85), which is
based on the MPK-1 activity-dependent nuclear export of the bio-
sensor (de la Cova et al, 2017). Images were recorded on a Leica wide-
ﬁeld microscope equipped with a piezo focus drive, a beam splitter,
and two scientiﬁc Complementary metal–oxide–semiconductor
cameras to simultaneously record the mCherry and mClover signals.
Weused custom-made ImageJ and CellProﬁler scripts provided in the
Supplemental Information to process and quantify the images taken
in the indicated mutant backgrounds under standardized illumi-
nation conditions. Flat ﬁeld illumination and background corrections
were done using blank and dark-ﬁeld images obtained for every
experiment. The nuclear RED/GREEN (mCherry::H2B/nKTR::mClover)
average intensity ratios were measured in each VPC (except for P3.p)
in summed z-projections of the ﬁve central slices (z-spacing of 0.2
μm) relative to the focus of the nuclear mCherry::H2B signal, using a
modiﬁed Cell Proﬁler script as described by de la Cova et al (2017). For
each VPC, the RED/GREEN nuclear ratio was normalized to the mean
of the RED/GREEN ratios in all VPCs in the same animal, and these
values are shown in the graphs of Fig 2. Statistical analysis was
carried out with one-way ANOVA followed by Dunnett’s multiple
comparison correction.
Hypoxic treatment
Hypoxic chambers were adapted from Fawcett et al (2012) as fol-
lows. Brieﬂy, a glass bowl with ﬂange served as container for small
Nematode Growth Medium plates. A customized lid was made,
which consists of an acrylic glass plate surrounded by a metal ring
equipped with an indentation to ﬁt in an O-ring. Two holes in the
acrylic glass served as the gas in- and output apertures. A third
larger hole accommodates an oxygen measuring device (GOX 100).
A hypoxic environment was generated via oxygen replacement by
N2 until the desired O2 concentration was obtained. Nematode
Growth Medium plates containing mixed-stage C. elegans were
incubated for 3 to 5 d and analyzed at the microscope.
Generation of the hif-1(zh111) null allele
CRISPR/CAS9 was performed as described in Friedland et al (2013),
Arribere et al (2014). 25 ng/μl dpy-10 sgRNApJA58was co-injected into
N2 Bristol animals with 25 ng/μl of a sgRNA targeting hif-1 (GATA-
GAAAAGTGAGTCCTAA), 500 nM of dpy-10(cn64) repair template AF-ZF-
827, and 50 ng/μl of pDD162. Candidate worms were selected from
plates harboring a large number of animals showing a roller phe-
notype progeny and analyzed by PCR. The zh111 deletion spans 2,464
bp and removes three to ﬁve exons (region upstream: ATTT-
CAAAAAATTTTTGACA; region downstream: CTAAGTTAAAAAAACAACAG).
Generation of let-60(zh121) and let-60(zh122)
The sgRNA sequence AATGACGGAGTACAAGCTTG was inserted into
plasmid #46169 (PU6::unc-119_sgRNA) via site-directed mutagenesis.
The let-60 genomic locus was partially ampliﬁed using the primers
AAGGAGCAAATCGAACAGAC and ATCCATTTTATTAGGCACGCAC and cloned
into p-GEM-T easy. The silently mutated PAM and the G13E mutation
were obtained using the primers TGAGTGCTGATTTACCAACTCCTC-
CATCTCCAACTACCACAAGCTTGTACTCCGTC and AAGCTTGTGGTAGTTGGA-
GATGGAGGAGTTGGTAAATCAGCACTCACCATTCAACTCATC. N2 Bristol or
CB4856 Hawaii animals were injected with 50 ng/μl sgRNA plasmid,
50 ng/μl pDD162, 50 ng/μl repair template, and 5 ng/μl pCFJ104. The
progeny was screened for the multivulva phenotype, and candidate
animals were veriﬁed by PCR and sequencing.
Translational nhr-57 reporter
A 1,206-bp fragment upstream of the nhr-57 transcriptional start
site was ampliﬁed together with the coding genomic region (without
the stop codon) using the primers ctaacaacttggaaatgaaatCACCAA-
CACCTTCTACACAGCTGC and gttcttctcctttactcatTTGTCCATCAA-
TGATTTTATAGATTTTGTCG. The gfp sequence was ampliﬁed from
pPD95.75 using the primers ATGAGTAAAGGAGAAGAAC and
gagatctggttcaaatagCTATTTGTATAGTTCATCCATGC. 459 bp of the nhr-57
39 UTR were ampliﬁed using the primers GCTATTTGAACCAGATCTCTTC
and cagtacggccgactagtagGAATAAATCATCCCAAAGCCGTTTTTG. A vector
backbone containing a CB-unc-119(+) rescue as well as the AmpR
gene was ampliﬁed using the primers ATTTCATTTCCAAGTTGTTAGCG
and CTACTAGTCGGCCGTACTGAGGTGTTGTCGCTT-TTATTGGG. The four
fragments were combined into a 10.170-kb plasmid (pSMa32) using
Gibson Assembly. N2 animals were injected (because of mutation in
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the CB-unc-119(+) gene) with 5 ng/μl pSMa32, 2.5 ng/μl pCFJ104 and
100 ng/μl pBS. Transformants were isolated based on the presence
of the co-injection marker.
Supplementary Information
Supplementary Information is available at https://doi.org/10.26508/lsa.
201800255.
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